HC Wainwright Reaffirms “Buy” Rating for GRI Bio (NASDAQ:GRI)
GRI Bio (NASDAQ:GRI – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a note issued to investors on Monday,Benzinga reports. They currently have a $10.00 price target on the stock. GRI Bio Stock Up 4.0 % Shares of NASDAQ GRI opened at $1.57 on Monday. The […]
